Hepatitis B surface protein docked vesicular carrier for site specific delivery to liver

Journal of Drug Targeting

Volumn 13, Issue 6, 2005, Pages 359-366

  Khatri, Kapil ^a   Rawat, Amit ^a   Mahor, Sunil ^a   Gupta, Prem N ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Asialoglycoproteins; Hepatitis B surface antigen (HBsAg); Hepatocytes; Liposomes; Receptor mediated endocytosis

Indexed keywords

CARBON 14; CELL RECEPTOR; CHOLESTEROL; CYANAMIDE; DRUG CARRIER; HEPATITIS B SURFACE ANTIGEN; LIGAND; LIPOSOME; PENTOBARBITAL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FRACTIONATION; CELL STRAIN HEPG2; CELL VACUOLE; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; DRUG ACCUMULATION; DRUG BINDING; DRUG TARGETING; DRUG UPTAKE; EGG; ENDOCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; LAMELLAR BODY; LIVER CELL; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SOLUBILITY;

ANIMALS; ASIALOGLYCOPROTEINS; DRUG DELIVERY SYSTEMS; HEPATITIS B SURFACE ANTIGENS; LIPOSOMES; LIVER; MALE; MICE; MICE, INBRED BALB C; RATS;

EID: 28044454794     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860500230294     Document Type: Article

References (27)

1. Allen TM, Brandeis E, Hansen CB, Kao GY, Zalipsky S. 1995. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta 1237:99-108.
2. Bogdanov Jr., AA, Klibanov AL, Torchilin VP. 1988. Protein immobilization on the surface of liposomes via carbodiimide activation in the presence of N-hydroxysulfosuccinimide. FEBS Lett 231:381-384.
3. de Vrueh RL, Rump ET, van De Bilt E, van Veghel R, Balzarini J, Biessen EA, van Berkel TJ, Bijsterbosh, MK. 2000. Carrier mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: A novel therapeutic approach for hepatitis B. Antimicrob Agents Chemother 44:477-483.
4. Dubey PK, Mishra V, Jain S, Mahor S, Vyas SP. 2004. Liposomes modified with cyclic RGD peptide for tumor targeting. J Drug Target 12:1-8.
5. Fiume L, Di Stefano G, Busi C, Mattioli A, Bonino F, Torrani-Ceranzia M, Verme G, Bertini M, Gervasi GB. 1997. Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor. J Viral Hepatitis 4:363-370.
6. Gregoriadis G, McCormack B, Obrenovic M, Saffie R, Zadi B, Perrie Y. 1999. Liposomes as immunological adjuvants and vaccine carriers. Methods 19:156-162.
7. Han JH, Oh YK, Kim DS, Kim CK. 1999. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier. Int J Pharm. 188:39-47.
8. Hattori Y, Kawakami S, Yamashita F, Hashida M. 2000. Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting. J Control Rel 69:369-377.
9. Kawakami S, Wong J, Sato A, Hattori Y, Yamashita F, Hashida M. 2000. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim Biophys Acta 1524:258-265.
10. Kono K, Igawa T, Takagishi T. 1997. Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly ethylene glycol derivative. Biochim Biophys Acta 1325:143-154.
11. Kooistra T, Duursma AM, Bouma JWM, Gruber M. 1979. Biochim Biophys Acta 587:282-298.
12. Li H, Qian ZM. 2002. Transferrin/transferrin receptor mediated drug delivery. Med Res Rev 22:225-250.
13. Makdisi WJ, Wu CH, Wu GY. 1992. Methods of gene transfer into hepatocytes: Progress towards gene therapy. In: Boyer JL, Oakner KK, editors. Progress in Liver Diseases. Philadelphia: Saunders. p 1-24.
14. Martinez-Fong D, Mullersman JE, Purchio AF, Armendariz-Borunda J, Martinez-Herandez A. 1994. Nonenzymatic glycosylation of poly-L-lysine: A new tool for targeted gene delivery. Hepatology 20:1602-1608.
15. Meets P. 2001. Enzyme-activated targeting of liposomes. Adv Drug Deliv Rev 53:265-272.
16. Ogawara K, Nishikawa M, Takakura Y, Hashida M. 1998. Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver. J Control Rel 50:309-317.
17. Schwartz AL. 1995. Receptor cell biology: Receptor mediated endocytosis. Pediatr Res 38:835-843.
18. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
19. Stockert RJ. 1995. The asialoglycoprotein receptor: Relationships between structure, function and expression. Physiol Rev 75:591-609.
20. Tiollais P, Pourcel C, Dejean A. 1985. The hepatitis B virus. Nature 317:489-495.
21. Treichel U, Meyer zumBuschenfelde KH, Dienes HP, Gerken G. 1997. Receptor-mediated entry of hepatitis B virus particles into liver cells. Arch Virol 142:493-498.
22. Vingerhoeds MH, Storm G, Crommelin DJ. 1994. Immunoliposomes in vivo. Immunomethods 4:259-272.
23. Vyas SP, Sihorkar V. 2000. Endogenous carriers and ligands in non-immunogenic site specific drug delivery. Adv Drug Deliv Rev 43:101-164.
24. Vyas SP, Katare YK, Mishra V, Sihorkar V 2000. Ligand directed macrophage targeting of amphotericin B loaded liposomes. Int J Pharm 210:1-14.
25. Vyas SP, Singh A, Sihorkar V. 2001. Ligand-receptor mediated drug delivery: An emerging paradigm in cellular drug targeting. Crit Rev Ther Drug Carrier Sys 18:1-76.
26. Wu J, Liu P, Zhu JL, Maddukuri S, Zern MA. 1998. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents. Hepatology 27:772-778.
27. Yao T, Esposti SD, Huang L, Arnon R, Spangenberger A, Zern MA. 1994. Inhibition of carbon tetrachloride-induced liver injury by liposomes containing vitamin E. Am J Physiol 267:G476-G484.